A weekly look at the health news that matters to you. Dr. Brian Goldman brings you the best science from top experts in plain language. He cuts through the BS and confusion to give you a dose of smart advice that you won’t find anywhere else. New episodes every Thursday.
A weekly look at the health news that matters to you. Dr. Brian Goldman brings you the best science from top experts in plain language. He cuts through the BS and confusion to give you a dose of smart advice that you won’t find anywhere else. New episodes every Thursday.
A new Health Canada-approved drug called lecanemab has been shown to slow early-stage Alzheimer's disease. Neurologist Dr. Sharon Cohen, who participated in phase three trials for the drug, explains why lecanemab is such a big deal.
For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.